Quanterix (QTRX)
Quanterix Corporation, a life sciences company in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrume...
- Open
- 2.630
- High
- 2.945
- Low
- 2.470
- Prev. Close
- 2.625
- Volume
- 1.27M
- Turnover
- 3.47M
- Avg Price
- 2.739
- Bid/Ask Ratio
- --
- Amplitude
- 18.10%
- 52wk High
- 8.770
- Volume Ratio
- 2.96
- Turnover Ratio
- 3.38%
Quanterix Analyst Rating
View moreForecast & Rating
Aug 10, 2026Price forecast
$3.3313.77%
Forecast & RatingHold
3analysts
- Strong buy0.00%
- Buy0.00%
- Hold100.00%
- Sell0.00%
- Strong sell0.00%
News
- Quartr · 10 hours ago
QTRX: Diagnostics and clinical trials growth, new leadership, and synergy gains drive optimism for 2024
- Tip Ranks · 1 day ago, 01:01 AM
Quanterix Warns of Broad Risk Exposure Despite No New Material Changes in Latest 10-Q
- Fiercepharma · 2 days ago, 08:43 AM
Quanterix hires GE Healthcare, Exact Sciences alum as CCO
- TradingView · 2 days ago, 07:41 AM
Quanterix Corp 2026: Revenue $32.91M, EPS ($1.04) — 10-Q Summary
- Quartr · 2 days ago, 07:16 AM
QTRX: Revenue up 34% year-over-year, but 2026 outlook lowered amid market softness and execution challenges
- PUBT · 2 days ago, 07:07 AM
Quanterix names Jim Gute chief commercial officer
